The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Autores principales: | , , , , , , |
|---|---|
| Otros Autores: | |
| Formato: | Conference item |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Sumario: |
|---|